Laminin receptor activation inhibits endothelial tissue factor expression

Journal of Molecular and Cellular Cardiology

Volumn 48, Issue 6, 2010, Pages 1138-1145

  Holy, Erik W ^a,b   Stämpfli, Simon F ^a,b   Akhmedov, Alexander ^a   Holm, Niels ^a   Camici, Giovanni G ^a   Lüscher, Thomas F ^a,b   Tanner, Felix C ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

67 kDA laminin receptor; Epigallocatechin 3 gallate; Laminin; MAP kinase; Tissue factor

Indexed keywords

EPIGALLOCATECHIN GALLATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LAMININ RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE 1; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING;

ANIMALS; CAROTID ARTERIES; CELL NUCLEUS; ENDOTHELIUM; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 8; RECEPTORS, LAMININ; TEA; THROMBOPLASTIN; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 77952673980     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.08.012     Document Type: Article

References (31)

1. Mackman N., Tilley R.E., Key N.S. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1687-1693.
2. Steffel J., Luscher T.F., Tanner F.C. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 2006, 113:722-731.
3. Luscher T.F., Steffel J., Eberli F.R., Joner M., Nakazawa G., Tanner F.C., et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 2007, 115:1051-1058.
4. Toschi V., Gallo R., Lettino M., Fallon J.T., Gertz S.D., Fernandez-Ortiz A., et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 1997, 95:594-599.
5. Davis GE, Senger DR Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ. Res. 2005, 97. 1093-07.
6. Liu Y., Senger D.R. Matrix-specific activation of Src and Rho initiates capillary morphogenesis of endothelial cells. FASEB J. 2004, 18:457-468.
7. Hallmann R., Horn N., Selg M., Wendler O., Pausch F., Sorokin L.M. Expression and function of laminins in the embryonic and mature vasculature. Physiol. Rev. 2005, 85:979-1000.
8. Nelson J., McFerran N.V., Pivato G., Chambers E., Doherty C., Steele D., et al. The 67kDa laminin receptor: structure, function and role in disease. Biosci Rep. 2008, 28:33-48.
9. Gloe T, Riedmayr S, Sohn HY, Pohl U The 67-kDa laminin-binding protein is involved in shear stress-dependent endothelial nitric-oxide synthase expression. J. Biol. Chem. 1999, 274. 15996-02.
10. Tachibana H., Koga K., Fujimura Y., Yamada K. A receptor for green tea polyphenol EGCG. Nat. Struct. Mol. Biol. 2004, 11:380-381.
11. Chyu K.Y., Babbidge S.M., Zhao X., Dandillaya R., Rietveld A.G., Yano J., et al. Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice. Circulation 2004, 109:2448-2453.
12. El Bedoui J., Oak M.H., Anglard P., Schini-Kerth V.B. Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression. Cardiovasc. Res. 2005, 67:317-325.
13. Kim J.A., Formoso G., Li Y., Potenza M.A., Marasciulo F.L., Montagnani M., Quon M.J. Epigallocatechin gallate, a green tea polyphenol, mediates NO-dependent vasodilation using signaling pathways in vascular endothelium requiring reactive oxygen species and Fyn. J. Biol. Chem. 2007, 282:13736-13745.
14. Lorenz M., Wessler S., Follmann E., Michaelis W., Dusterhoft T., Baumann G., et al. A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation. J. Biol. Chem. 2004, 279:6190-6195.
15. Stangl V., Dreger H., Stangl K., Lorenz M. Molecular targets of tea polyphenols in the cardiovascular system. Cardiovasc. Res. 2007, 73:348-358.
16. Lorenz M., Urban J., Engelhardt U., Baumann G., Stangl K., Stangl V. Green and black tea are equally potent stimuli of NO production and vasodilation: new insights into tea ingredients involved. Basic Res. Cardiol. 2009, 104:100-110.
17. Debette S., Courbon D., Leone N., Gariepy J., Tzourio C., Dartigues J.F., et al. Tea consumption is inversely associated with carotid plaques in women. Arterioscler. Thromb. Vasc. Biol. 2008, 28:353-359.
18. Kuriyama S., Shimazu T., Ohmori K., Kikuchi N., Nakaya N., Nishino Y., et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 2006, 296:1255-1265.
19. Wolfram S. Effects of green tea and EGCG on cardiovascular and metabolic health. J. Am. Coll. Nutr. 2007, 26:373-388.
20. Gebhard C., Stämpfli S.F., Gebhard C.E., Akhmedov A., Breitenstein A., Camici G.G., et al. Guggulsterone, an anti-inflammatory phytosterol, inhibits tissue factor and arterial thrombosis. Basic Res. Cardiol. 2009, 104:285-294.
21. Holy E.W., Akhmedov A., Luscher T.F., Tanner F.C. Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells. J. Mol. Cell. Cardiol. 2009, 46:234-240.
22. Böse D., Leineweber K., Konorza T., Zahn A., Bröcker-Preuss M., Mann K., et al. Release of TNF-alpha during stent implantation into saphenous vein aortocoronary bypass grafts and its relation to plaque extrusion and restenosis. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:2295-2299.
23. Parry G.C., Mackman N. Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 1995, 15:612-621.
24. Givant-Horwitz V., Davidson B., Reich R. Laminin-induced signaling in tumor cells. Cancer Lett. 2005, 223:1-10.
25. Steffel J., Arnet C., Akhmedov A., Iseli S.M., Luscher T.F., Tanner F.C. Histamine differentially interacts with tumor necrosis factor-alpha and thrombin in endothelial tissue factor induction: the role of c-Jun NH2-terminal kinase. J. Thromb. Haemost. 2006, 4:2452-2460.
26. Bayat H., Xu S., Pimentel D., Cohen R.A., Jiang B. Activation of thromboxane receptor upregulates interleukin (IL)-1beta-induced VCAM-1 expression through JNK signaling. Arterioscler. Thromb. Vasc. Biol. 2008, 28:127-134.
27. Lin S.J., Shyue S.K., Hung Y.Y., Chen Y.H., Ku H.H., Chen J.W., et al. Superoxide dismutase inhibits the expression of vascular cell adhesion molecule-1 and intracellular cell adhesion molecule-1 induced by tumor necrosis factor-alpha in human endothelial cells through the JNK/p38 pathways. Arterioscler. Thromb. Vasc. Biol. 2005, 25:334-340.
28. Zhou Z., Connell M.C., MacEwan D.J. TNFR1-induced NF-kappaB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells. Cell. Signal. 2007, 19:1238-1248.
29. Liu Y., Pelekanakis K., Woolkalis M.J. Thrombin and tumor necrosis factor alpha synergistically stimulate tissue factor expression in human endothelial cells: regulation through c-Fos and c-Jun. J. Biol. Chem. 2004, 279:36142-36147.
30. Ullmann U., Haller J., Decourt J.P., Girault N., Girault J., Richard-Caudron A.S., et al. A single ascending dose study of epigallocatechin gallate in healthy volunteers. J. Int. Med. Res. 2003, 31:88-101.
31. Yang C.S., Chen L., Lee M.J., Balentine D., Kuo M.C., Schantz S.P. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol. Biomark. Prev. 1998, 7:351-354.